The global virus filtration market size is expected to reach USD 9.5 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 10.1% from 2023 to 2030. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.
Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.
Request a free sample copy or view report summary: Virus Filtration Market Report
The consumables segment dominated the market with the largest revenue share in 2022 owing to the rising demand for these products for virus filtration.
Chromatography technology segment is expected to grow at the fastest CAGR during the forecast period, owing to product advancements and increasing R&D and production of biologics.
Biologicals segment held the largest revenue share of 56.6% in 2022 and is expected to grow at the fastest CAGR of 10.9% over the forecast period due to rising prevalence of chronic diseases such as cancer, blood disorders, and diabetes
The biotechnology and biopharmaceutical companies segment is projected to expand at the fastest CAGR over the forecast period owing to increasing investment in R&D and production of biologics
North America led the virus filtration market with the largest revenue share of 41.2% in 2022. Primarily due to the presence of several leading biotechnology companies and increased R&D activities
Asia Pacific is estimated to grow at the fastest CAGR of 12.0% over the forecast period from 2023 to 2030 due to the growing number of road accidents and trauma cases.
Grand View Research has segmented the global virus filtration market based on product, technology, application, end-use, and region:
Virus Filtration Product Outlook (Revenue, USD Million, 2018 - 2030)
Consumables
Kits and Reagents
Others
Instruments
Filtration Systems
Chromatography Systems
Services
Virus Filtration Technology Outlook (Revenue, USD Million, 2018 - 2030)
Filtration
Consumables
Instruments
Services
Chromatography
Consumables
Instruments
Services
Virus Filtration Application Outlook (Revenue, USD Million, 2018 - 2030)
Biologicals
Vaccines and Therapeutics
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Stem Cell Products
Medical Devices
Water Purification
Air Purification
Virus Filtration End-use Outlook (Revenue, USD Million, 2018 - 2030)
Biopharmaceutical & Biotechnology Companies
Contract Research Organizations
Medical device companies
Academic Institutes & Research Laboratories
Virus Filtration Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Virus Filtration Market
Merck KGaA
Danaher
Sartorius AG
Thermo Fisher Scientific Inc.
GE Healthcare
Charles River Laboratories
Asahi Kasei Medical Co., Ltd.
WuXi AppTec
Lonza
Clean Biologics
"The quality of research they have done for us has been excellent..."